Professor
Friedman School of Nutrition Science and Policy at Tufts University
John Hancock Research Center on Physical Activity, Nutrition, and Obesity Prevention
Boston, Massachusetts, United States
Christina Economos, PhD is the Dean at the Friedman School of Nutrition Science and Policy at Tufts University where she is a professor and the New Balance Chair in Childhood Nutrition. Dr. Economos currently serves as the principal investigator on multiple large-scale, community-based interventions that examine childhood nutrition and physical activity with the goal of improving the health of all of America's children. Her bio-behavioral research studies are interdisciplinary and include theory-based obesity prevention interventions, cutting edge systems science, and partnerships with diverse populations in urban and rural communities in schools, out-of-school environments, childcare centers, and restaurants. She has authored more than 200 scientific publications. She serves as Vice Chair of the Roundtable on Obesity Solutions (ROOS) at the National Academies of Science, Engineering, and Medicine in Washington DC, a multisector group tackling obesity. Dr. Economos received a Bachelor of Science from Boston University, a Master of Science in Applied Physiology and Nutrition from Columbia University and a Doctorate in Nutritional Biochemistry from Tufts University.
Biomarkers of Nutrition for Development: Knowledge Indicating Dietary Sufficiency
Sunday, July 23, 2023
8:00 AM – 9:30 AM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Sunday, July 23, 2023
9:00 AM – 9:15 AM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Panel Discussion - Biomarkers of Nutrition for Development: Knowledge Indicating Dietary Sufficiency
Sunday, July 23, 2023
9:15 AM – 9:30 AM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Sunday, July 23, 2023
10:24 AM – 10:36 AM ET
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.